• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

testosterone

Pharma

Clarus' fate in limbo as lead drug Jatenzo sputters

Some two years after braving the pandemic to launch its oral testosterone replacement tablet Jatenzo, Clarus Therapeutics is in dire straits.
Fraiser Kansteiner Aug 19, 2022 10:35am

Antares, Lipocine win FDA nod for oral testosterone med

Mar 29, 2022 11:42am

After dropping case, FTC urges for new legislation

Aug 2, 2021 10:54am

Drugmakers blaze a path for new therapy launches during COVID-19

Jun 18, 2020 11:00am

Antares wins FDA nod for testosterone drug Xyosted

Oct 1, 2018 11:27am

AbbVie nears settlement covering 4,000-plus AndroGel cases

Sep 11, 2018 10:35am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy